Evicenter
MarkdownMedical informationP&T meetings
Onvuzosiran (ADX-324)

Prophylaxis of hereditary angioedema attacks

Launch
Not announced
Last updated
119 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of hereditary angioedema

Economic impact of hereditary angioedema on families

3 evidence topics · 3 sources